Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Nineteen were still open at inspection close
Key drivers fueling this momentum include a strong product pipeline with innovative molecules and combination therapies, and increased healthcare spending in emerging economies
Germany leads with 17.0% in 2025, rising to 18.0% by 2035, supported by strong medical-wellness adoption across Berlin, Munich, Frankfurt, and Hamburg
(2011) 301:H218190
Antibodies against MARCO (Abcam, clone EPR22944-66, catalog ab259264, 1:200), F4/80 (Invitrogen, Thermo Fisher Scientific, clone CI:A3-1, catalog MA1-91124, 1:250), and CLEC4F (R&D Systems, Bio-Techne, catalog AF2784, 1:200) were incubated overnight at 4C
US$ 29.17
US$ 25.80
US$ 25.21
US$ 27.11
US$ 21.88
US$ 26.77
